Inhibitors of CXCL5 or its receptor CXCR2 could be potentially applied in clinic in different mechanisms, such as regulating the tumor immune microenvironment, reducing angiogenesis and progression, improving treatment utility by combination therapy.37 Here, CXCR2 is linked to neoplasm.